CXCR3-Expressing T Cells in Infections and Autoimmunity

The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting t...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in bioscience (Landmark. Print) Vol. 29; no. 8; p. 301
Main Authors Rubinstein, Artem, Kudryavtsev, Igor, Arsentieva, Natalia, Korobova, Zoia R, Isakov, Dmitry, Totolian, Areg A
Format Journal Article
LanguageEnglish
Published Singapore IMR Press 22.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3 Treg cells, and Tc1 CD8 T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4 and CD8 T cells that upregulate inflammation, and also for recruitment of CXCR3 T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.
AbstractList The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.
The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3 Treg cells, and Tc1 CD8 T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4 and CD8 T cells that upregulate inflammation, and also for recruitment of CXCR3 T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.
The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both in the protective responses to invading pathogens, and in different pathological conditions associated with autoimmunity. It is worth noting that CXCR3 is highly expressed on innate and adaptive lymphocytes, as well as on various cell subsets that are localized in non-immune organs and tissues. Our review focuses exclusively on CXCR3-expressing T cells, including Th1, Th17.1, Tfh17, Tfh17.1, CXCR3+ Treg cells, and Tc1 CD8+ T cells. Currently, numerous studies have highlighted the role of CXCR3-dependent interactions in the coordination of inflammation in the peripheral tissues, both to increase recruitment of CD4+ and CD8+ T cells that upregulate inflammation, and also for recruitment of CXCR3+ T regulatory cells to dampen overexuberant responses. Understanding the role of CXCR3 and its ligands might help to apply them as new and effective therapeutic targets in a wide range of diseases.
Author Isakov, Dmitry
Rubinstein, Artem
Arsentieva, Natalia
Totolian, Areg A
Kudryavtsev, Igor
Korobova, Zoia R
Author_xml – sequence: 1
  givenname: Artem
  surname: Rubinstein
  fullname: Rubinstein, Artem
  organization: Department of Immunology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia
– sequence: 2
  givenname: Igor
  surname: Kudryavtsev
  fullname: Kudryavtsev, Igor
  organization: Department of Immunology, Institute of Experimental Medicine, 197376 Saint Petersburg, Russia
– sequence: 3
  givenname: Natalia
  surname: Arsentieva
  fullname: Arsentieva, Natalia
  organization: Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia
– sequence: 4
  givenname: Zoia R
  surname: Korobova
  fullname: Korobova, Zoia R
  organization: Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia
– sequence: 5
  givenname: Dmitry
  surname: Isakov
  fullname: Isakov, Dmitry
  organization: Department of Immunology, Medical Faculty, First Saint Petersburg State I. Pavlov Medical University, 197022 Saint Petersburg, Russia
– sequence: 6
  givenname: Areg A
  surname: Totolian
  fullname: Totolian, Areg A
  organization: Laboratory of Immunology, Saint Petersburg Pasteur Institute, 197101 Saint Petersburg, Russia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39206903$$D View this record in MEDLINE/PubMed
BookMark eNpFkEtLw0AURgepaK0u3UqWblLn1XksJVQtCIIouBsm85AJyUzNJGD_vaG1urofl8O53O8CzGKKDoBrBJcEQUHumqWvWyynCNEJmGPORMmYFLNj5hCdg6ucGwghlgjJlTgD50RiyCQkc8Crj-qVlOvvbe9yDvGzeCsq17a5CLHYRO_MEFLMhY62uB-HFLpujGHYXYJTr9vsrn7nArw_rN-qp_L55XFT3T-XBgs6lMxT4SUhzjpjVwxJiT0jXqw8qrFGtbOQ1lwIYo2hmBpGpGHMaWgJZ8xqsgCbg9cm3ahtHzrd71TSQe0Xqf9Uuh-CaZ3iWGtHnbfcEmq4kRJxL5iBpvacUTu5bg-ubZ--RpcH1YVspmd1dGnMikApueSUwwktD6jpU86983-nEVT76lWj_quf-Jtf9Vh3zv7Rx6LJDzkTf6Q
ContentType Journal Article
Copyright 2024 The Author(s). Published by IMR Press.
Copyright_xml – notice: 2024 The Author(s). Published by IMR Press.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOA
DOI 10.31083/j.fbl2908301
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2768-6698
ExternalDocumentID oai_doaj_org_article_72aae4efd7d34c7c9917f86c0cbf764d
10_31083_j_fbl2908301
39206903
Genre Journal Article
Review
GrantInformation_xml – fundername: Saint Petersburg Pasteur Institute via the State Task
  grantid: 121030200299-3
– fundername: Institute of Experimental Medicine via the State Task
  grantid: 075-01135-22-00
GroupedDBID 3IV
53G
AAFWJ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
CGR
CUY
CVF
ECM
EIF
GROUPED_DOAJ
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c284t-6f48f933edecd561992f63f85f1b2a1bed04b7883dcc424c639c66ea0d3766da3
IEDL.DBID DOA
ISSN 2768-6701
2768-6698
IngestDate Tue Oct 22 15:16:30 EDT 2024
Sat Oct 26 04:12:02 EDT 2024
Wed Sep 04 12:46:52 EDT 2024
Sat Nov 02 12:25:57 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Keywords COVID-19
infection
Tc1
Th1 cells
Th17.1 cells
autoimmunity
CXCR3 chemokines
CXCR3
Treg
CXCR3 receptor
follicular Th cell subsets
Language English
License 2024 The Author(s). Published by IMR Press.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c284t-6f48f933edecd561992f63f85f1b2a1bed04b7883dcc424c639c66ea0d3766da3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://doaj.org/article/72aae4efd7d34c7c9917f86c0cbf764d
PMID 39206903
PQID 3099797470
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_72aae4efd7d34c7c9917f86c0cbf764d
proquest_miscellaneous_3099797470
crossref_primary_10_31083_j_fbl2908301
pubmed_primary_39206903
PublicationCentury 2000
PublicationDate 2024-08-22
PublicationDateYYYYMMDD 2024-08-22
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-22
  day: 22
PublicationDecade 2020
PublicationPlace Singapore
PublicationPlace_xml – name: Singapore
PublicationTitle Frontiers in bioscience (Landmark. Print)
PublicationTitleAlternate Front Biosci (Landmark Ed)
PublicationYear 2024
Publisher IMR Press
Publisher_xml – name: IMR Press
SSID ssj0002911958
Score 2.3142297
SecondaryResourceType review_article
Snippet The chemokine receptor CXCR3 and its ligands (MIG/CXCL9, IP-10/CXCL10, and I-TAC/CXCL11) play a central role in the generation of cellular inflammation, both...
SourceID doaj
proquest
crossref
pubmed
SourceType Open Website
Aggregation Database
Index Database
StartPage 301
SubjectTerms Animals
Autoimmune Diseases - immunology
Autoimmune Diseases - metabolism
autoimmunity
Autoimmunity - immunology
covid-19
cxcr3 chemokines
cxcr3 receptor
cxcr3+ treg
follicular th cell subsets
Humans
infection
Infections - immunology
Inflammation - immunology
Inflammation - metabolism
Receptors, CXCR3 - immunology
Receptors, CXCR3 - metabolism
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
tc1
th1 cells
th17.1 cells
Title CXCR3-Expressing T Cells in Infections and Autoimmunity
URI https://www.ncbi.nlm.nih.gov/pubmed/39206903
https://www.proquest.com/docview/3099797470
https://doaj.org/article/72aae4efd7d34c7c9917f86c0cbf764d
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA4iCF7Et_XFCuItNq9NmmMtFhX0IAq9LXlKpWzFbsH-eye7W_UiXrwtYWHDN9mZb5LJNwidQ8iwNmiJKQ0EC8Ei1oJHbGgQJLpcxJhOdO8f5M2zuBvlox-tvlJNWCMP3ADXVcyYIEL0ynPhlAM-o2JPOuJsVFL42vsS_SOZSj6Y6SRlVrejAz6NpSK0EdgENtPj3dfLaCdMw2PbDGYZkGrd_t_JZh10hptoo2WLWb-Z5RZaCeU2Wmv6Ry52kBqMBo8cX3801azlS_aUDcJkMsvGZXbbllmVs8yUPuvPq-m4vgxSLXbR8_D6aXCD204I2EH4qLCMohc158EH54HxaM2i5LGXR2qZoTZ4Iiwks9w7J5hwQDuclMEQD_5DesP30Go5LcMBynLi4Cc1zsTARaS5zRW1wMI0YCaNoh10sYSjeGsELwpIFGrcIFP4xq2DrhJYXy8lnep6AKxXtNYr_rJeB50toS5gXafDClOG6XxW8HSlNyU7pIP2Gxt8fQo4XRJY5of_MYUjtM6AqKR9YsaO0Wr1Pg8nQDQqe1qvqU9Zec4j
link.rule.ids 315,783,787,867,2109,27936,27937
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=CXCR3-Expressing+T+Cells+in+Infections+and+Autoimmunity&rft.jtitle=Frontiers+in+bioscience+%28Landmark.+Print%29&rft.au=Artem+Rubinstein&rft.au=Igor+Kudryavtsev&rft.au=Natalia+Arsentieva&rft.au=Zoia+R.+Korobova&rft.date=2024-08-22&rft.pub=IMR+Press&rft.issn=2768-6701&rft.volume=29&rft.issue=8&rft.spage=301&rft_id=info:doi/10.31083%2Fj.fbl2908301&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_72aae4efd7d34c7c9917f86c0cbf764d
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2768-6701&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2768-6701&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2768-6701&client=summon